Attached files
| file | filename |
|---|---|
| 8-K - 8-K/A PCRX 2-26-16 - Pacira BioSciences, Inc. | pcrx8-kafeb262016.htm |
Exhibit 16.1
February 26, 2016
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7561
Dear Sirs/Madams:
We have read the statements made by Pacira Pharmaceuticals, Inc., which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K/A, as part of the Form 8-K/A of Pacira Pharmaceuticals, Inc. dated February 26, 2016. We agree with the statements concerning our Firm in such Form 8-K/A.
Very truly yours,
Roseland, New Jersey